BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
DBV Technologies annonce son intention de modifier le ratio d'ADS
May 17, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 17 mai 2024 DBV Technologies annonce son intention de modifier le ratio d'ADS DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP:...
DBV Technologies Announces Plan to Implement ADS Ratio Change
May 17, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a...
Oculis updates share capital for its existing at-the-market offering program
May 17, 2024 16:30 ET
|
Oculis Holding AG
ZUG, May 17, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
May 17, 2024 16:30 ET
|
Primech Holdings Ltd.
SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and...
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing
May 17, 2024 16:30 ET
|
Nvni Group Limited
Nvni Group Limited announced that it received a notice from Nasdaq indicating the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1).
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing
May 17, 2024 16:30 ET
|
DZS
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing
OceanPal Inc. Announces Results of 2024 Annual Meeting of Shareholders
May 17, 2024 16:10 ET
|
OceanPal Inc.
ATHENS, Greece, May 17, 2024 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that the Company’s...
Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
May 17, 2024 16:10 ET
|
Virios Therapeutics
ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...